Ronca et al. showed that PTX3 overexpressed-transgenic mice inhibited tumor growth, angiogenesis, and metastasis, and suggested that the implications in cancer therapy of the small-molecule chemical NSC12 is a PTX3- derived anti-FGF small molecule24. Here, PTX3 is linked to neoplasm.